Clinical Trial Update: A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for docetaxel albumin-bound in gastric cancer (gastric adenocarcinoma and adenocarcinoma of GEJ) is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of Gastroesophageal Junction
• Gastric Adenocarcinoma

Drugs mentioned

• Docetaxel for Injection (Albumin Bound) (docetaxel (albumin-bound formulation))

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction | Phase 2 | Status: UNKNOWN